CBRG files investor presentation for Phytanix Bio merger; no specific terms disclosed

Chain Bridge I

Investor presentation furnished as Exhibit 99.1 on July 29, 2024 for proposed business combination.
Presentation relates to July 22 Business Combination Agreement among CBRG, Phytanix Bio, and HoldCo.
No financial projections, valuation, or deal structure details provided in the available excerpt.
Presentation intended for use in meetings with investors regarding the Business Combination.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.